Unit 9: Radioisotope Production, Accelerators & Radionuclide Generators

Over $80\%$ of all radioisotopes used worldwide in medicine and industry are produced in nuclear research reactors (e.g., BR2 in Belgium, HFR in the Netherlands, OPAL in Australia, MURR in the USA).

Reactors produce radionuclides via two primary pathways:

1. Neutron Capture Reactions ($(n, \gamma)$):

A stable target isotope captures a thermal neutron:

Because the product is an isotope of the target element, chemical separation is impossible! The product is inherently carrier-added; its specific activity is limited by target burnup:

Examples:

• $^{59}_{27}\text{Co}(n, \gamma)^{60}_{27}\text{Co}$ ($T_{1/2} = 5.27\text{ yr}$) for industrial sterilization and cancer teletherapy.
• $^{191}_{77}\text{Ir}(n, \gamma)^{192}_{77}\text{Ir}$ ($T_{1/2} = 73.8\text{ days}$) for pipeline radiography and brachytherapy.

2. Fast Neutron Transmutation Reactions ($(n, p)$ and $(n, \alpha)$):

Fast fission neutrons ($E_n > 1\text{ MeV}$) induce charge-changing transmutation reactions:

Because the product is a different chemical element, it can be separated from the target matrix with $>99.99\%$ purity using ion-exchange chromatography or solvent extraction. The product is carrier-free (No-Carrier-Added, NCA), achieving maximum theoretical specific activity! Examples:

• $^{32}_{16}\text{S}(n, p)^{32}_{15}\text{P}$ ($T_{1/2} = 14.3\text{ days}$, pure beta emitter).
• $^{14}_{7}\text{N}(n, p)^{14}_{6}\text{C}$ ($T_{1/2} = 5,730\text{ yr}$).
• $^{6}_{3}\text{Li}(n, \alpha)^{3}_{1}\text{H}$ ($T_{1/2} = 12.32\text{ yr}$, tritium production).

The highest specific activity radionuclides are obtained by harvesting fission products from irradiated uranium targets:

Production of Fission Molybdenum-99 ($^{99}\text{Mo}$)

Molybdenum-99 is the parent of technetium-99m, the workhorse of nuclear medicine ($>30\text{ million}$ scans annually).

• Target: Enriched uranium targets ($19.75\%$ Low-Enriched Uranium, LEU) electroplated as uranium metal or aluminide foil inside a target pin.
• Irradiation: Irradiated in a reactor core for $5 - 7\text{ days}$ at thermal flux $\Phi \sim 10^{14}\text{ n/cm}^2\cdot\text{s}$. Fission yield for mass chain 99 is exceptionally high: $\gamma(^{99}\text{Mo}) = 6.13\%$.
• Chemical Extraction (Hot Cell Radiochemistry):

Within hours of discharge, the target is dissolved in boiling sodium hydroxide ($\text{NaOH}$) or nitric acid ($\text{HNO}_3$) behind lead hot-cell shielding. Uranium and actinides precipitate as insoluble hydrous oxides. The dissolved molybdate ($^{99}\text{MoO}_4^{2-}$) is purified through successive alumina and anion-exchange chromatography columns, achieving carrier-free specific activities exceeding $10,000\text{ Ci/gram}$ ($3.7 \times 10^{14}\text{ Bq/g}$).

Other critical carrier-free fission products:

• Iodine-131 ($^{131}_{53}\text{I}$): Fission yield $2.89\%$, extracted via thermal dry distillation of irradiated uranium or via tellurium neutron capture:

• Xenon-133 ($^{133}_{54}\text{Xe}$): Fission yield $6.70\%$, cryogenically trapped as a noble gas for lung ventilation imaging.

Particle accelerators produce proton-rich radionuclides that decay via positron emission ($\beta^+$) or electron capture (EC)—isotopes that cannot be produced in nuclear reactors.

Classical Cyclotron Kinematics (Lawrence, 1930)

A classical cyclotron accelerates charged ions (e.g., protons, deuterons) between two semicircular hollow D-shaped electrodes ("dees") housed in a high-vacuum chamber between the poles of an electromagnet. A particle of mass $m$ and charge $q$ moving with velocity $v$ in a perpendicular magnetic field $B$ experiences a centripetal Lorentz force:

The orbital revolution frequency is:

Notice that velocity $v$ and radius $r$ cancel out completely! As long as the particle remains non-relativistic ($m \approx m_0$), the revolution period is completely independent of its energy and orbital radius.

``` TOP VIEW OF CYCLOTRON DEES ┌─────────────────┐ ┌─────────────────┐ │ DEE 1 (-V) │ │ DEE 2 (+V) │ │ │ │ │ │ /───\ │ │ │ │ / ● \ │ │ │ ● Ion Source │ ( / \ ) │ │ │ │ \ / │ │ │ │ \───/ │ │ │ │ │ │ DEFLECTOR │ │ │ │ \ │ └─────────────────┘ └───────────\─────┘ \──► EXTRACTION TO TARGET ```

By applying an alternating radio-frequency (RF) voltage across the dee gap at resonance frequency $f_{\text{RF}} = f_{\text{cyc}}$, the particle receives an accelerating electrostatic kick $\Delta T = q V_{\text{dee}}$ twice per revolution, spiraling outward in expanding orbits.

Relativistic Relativistic Breakdown & Isochronous Cyclotrons

At relativistic energies, mass increases with the Lorentz factor:

As the particle accelerates, $\omega_{\text{cyc}}$ drops; the particle falls out of phase with the fixed RF frequency. Modern biomedical cyclotrons overcome this by using Isochronous (Azimuthally Varying Field, AVF) Cyclotrons: The magnetic field is engineered to increase radially ($B(r) \propto \gamma(r)$) using spiral-shaped iron pole sectors to provide strong alternating-gradient focusing, keeping $B / \gamma$ strictly constant up to $30\text{ MeV}$.

Positron Emission Tomography (PET) requires ultra-short-lived, positron-emitting radionuclides of the fundamental biological elements: carbon, nitrogen, oxygen, and fluorine (a bio-isostere of hydrogen). These radionuclides are synthesized on-site using compact, self-shielded hospital cyclotrons ($E_p \approx 11 - 18\text{ MeV}$):

| Radionuclide | Half-Life ($T_{1/2}$) | Nuclear Production Reaction | Target Chemical Matrix | Chemical Form Produced | Key Clinical Radiopharmaceutical | | :--- | :--- | :--- | :--- | :--- | :--- | | Fluorine-18 | $109.77\text{ min}$ | $^{18}\text{O}(p, n)^{18}\text{F}$ | Enriched Water ($\text{H}_2^{18}\text{O}, 98\%$) | $[^{18}\text{F}]\text{F}^-_{\text{aq}}$ (Fluoride) | $[^{18}\text{F}]\text{FDG}$ (2-Fluorodeoxyglucose, oncology) | | Carbon-11 | $20.36\text{ min}$ | $^{14}\text{N}(p, \alpha)^{11}\text{C}$ | High-Pressure Gas ($\text{N}_2 + 0.5\% \text{O}_2$) | $[^{11}\text{C}]\text{CO}_2$ | $[^{11}\text{C}]\text{Choline}, [^{11}\text{C}]\text{Methionine}$ | | Nitrogen-13 | $9.97\text{ min}$ | $^{16}\text{O}(p, \alpha)^{13}\text{N}$ | Natural Water ($\text{H}_2^{16}\text{O}$) + Ethanol | $[^{13}\text{N}]\text{NH}_3$ (Ammonia) | $[^{13}\text{N}]\text{NH}_3$ (Myocardial perfusion) | | Oxygen-15 | $122.24\text{ s}$ | $^{14}\text{N}(d, n)^{15}\text{O}$ | High-Pressure Gas ($\text{N}_2 + 1\% \text{O}_2$) | $[^{15}\text{O}]\text{O}_2, [^{15}\text{O}]\text{H}_2\text{O}$ | Cerebral blood flow / oxygen utilization |

Fluorine-18 Synthesis Chemistry

Fluorine-18 is the dominant PET isotope due to its optimal $110\text{ min}$ half-life, allowing commercial regional distribution:

1. Liquid target: $2.5\text{ mL}$ of enriched water ($\text{H}_2^{18}\text{O}$, costing $\sim \$50/\text{g}$) is irradiated with a $16.5\text{ MeV}$ proton beam at $40\,\mu\text{A}$ for $60 - 90\text{ minutes}$.
2. The aqueous $^{18}\text{F}^-$ is trapped on an anion-exchange cartridge (QMA Sep-Pak), while the expensive $\text{H}_2^{18}\text{O}$ is recovered for recycling.
3. The $^{18}\text{F}^-$ is eluted with potassium carbonate/Kryptofix 2.2.2 in acetonitrile.
4. Nucleophilic fluorination of mannose triflate followed by acid/base hydrolysis yields pure $^{18}\text{F-FDG}$ in an automated synthesis module within $30\text{ minutes}$.

A radionuclide generator (historically termed a "cow") is an on-site radiochemical separation apparatus that houses a long-lived parent radionuclide that decays into a short-lived daughter radionuclide. It enables hospitals thousands of miles from a nuclear reactor to obtain short-lived isotopes on demand.

The Physics of the $^{99}\text{Mo}/^{99m}\text{Tc}$ Couple

The generator exploits the parent-daughter decay relationship:

Key physical features:

• Parent $^{99}\text{Mo}$ half-life ($66\text{ h}$) is long enough for shipping across continents.
• Daughter $^{99m}\text{Tc}$ half-life ($6.0\text{ h}$) matches patient imaging procedures while minimizing radiation dose.
• Gamma emission: Clean, monoenergetic $140.5\text{ keV}$ photon ($89\%$ abundance) with zero particulate beta emission, perfectly matched to gamma camera NaI(Tl) crystal thickness ($3/8\text{ inch}$).

``` Activity on Generator Column (GBq) 100 ▲ │\ Parent ⁹⁹Mo (T₁/₂ = 66.0 h) │ \ Daughter ⁹⁹ᵐTc (Post-Milking In-growth) 80 │ \ /──────────────\ │ \ / \ 60 │ \ / \ │ \ / \ 40 │ \__________________________/ \_____ │ Milked (t = 0) Peak Activity (t_max ≈ 22.9 h) └─────────────────────────────────┴─────────────────────────────► Time t (Hours) ```

Chemical Architecture of the Alumina Column

The generator utilizes an acid-washed chromatographic column packed with high-purity acidic aluminum oxide ($\text{Al}_2\text{O}_3$):

1. At acidic $\text{pH} \approx 4 - 5$, the alumina surface acquires positive charges ($-\text{AlOH}_2^+$).
2. Carrier-free parent $^{99}\text{Mo}$ is loaded as divalent molybdate anions ($^{99}\text{MoO}_4^{2-}$). The high charge density ($-2$) binds firmly to the alumina surface:

1. As $^{99}\text{Mo}$ decays, it transmutes into technetium-99m, forming the monovalent pertechnetate anion ($^{99m}\text{TcO}_4^-$).
2. Because pertechnetate has only a single negative charge ($-1$) and a large ionic radius, its binding affinity for alumina is extremely weak.
3. Elution ("Milking"): Passing $5 - 10\text{ mL}$ of sterile, pyrogen-free $0.9\%\text{ NaCl}$ saline solution through the column selectively elutes the daughter as sodium pertechnetate ($\text{Na}^{99m}\text{TcO}_4$), while $99.999\%$ of the $^{99}\text{Mo}$ remains bound to the alumina!

Following elution of a $^{99}\text{Mo}/^{99m}\text{Tc}$ generator, the technetium activity on the column regenerates according to the Bateman transient growth formula:

Maximum activity is reached at:

At $t = 24\text{ hours}$, the daughter activity reaches $95\%$ of its theoretical maximum, establishing the universal clinical rhythm of daily morning milking.

Metrological Quality Assurance Standards

Before eluate can be administered to patients, strict pharmacopeial quality criteria must be satisfied:

1. Radionuclidic Purity (Molybdenum Breakthrough):

Contamination with parent $^{99}\text{Mo}$ ($T_{1/2} = 66\text{ h}$, energetic beta emitter) delivers unnecessary radiation dose to patient bone marrow.

• Assay: Eluate is placed inside a calibrated lead canister ($6\text{ mm}$ wall thickness). The $140\text{ keV}$ gammas of $^{99m}\text{Tc}$ are absorbed completely, while energetic $740\text{ keV}$ and $778\text{ keV}$ photons of $^{99}\text{Mo}$ penetrate the shield and are counted.
• US Pharmacopeia (USP) Regulatory Limit:

2. Chemical Purity (Aluminum Ion Breakthrough):

Alumina breakdown can release colloidal $\text{Al}^{3+}$ ions, which precipitate radiopharmaceutical complexes (e.g., flocculating sulfur colloid).

• Assay: Colorimetric spot test using aurintricarboxylic acid (aluminon) test strips.
• USP Limit: $[\text{Al}^{3+}] < 10\,\mu\text{g/mL}$ of eluate.

3. Radiochemical Purity:

Percentage of technetium existing in the correct chemical oxidation state (pertechnetate $\text{TcO}_4^-, \text{Tc(VII)}$ vs reduced hydrolyzed species $\text{TcO}_2$).

• Assay: Instant Thin-Layer Chromatography (ITLC).
• Limit: $>95\%$ pure pertechnetate.

Beyond technetium-99m, radiochemistry has developed specialized generator systems and industrial sealed sources:

1. The $^{68}\text{Ge}/^{68}\text{Ga}$ PET Generator System

The modern PET counterpart to the technetium generator:

• Column: Titanium dioxide ($\text{TiO}_2$) or tin dioxide ($\text{SnO}_2$).
• Elution: Eluted with dilute hydrochloric acid ($0.1\text{ M HCl}$) as gallium chloride ($[^{68}\text{Ga}]\text{Ga}^{3+}$).
• Advantage: A parent half-life of 9 months allows a single generator to supply a PET imaging center with positron-emitting $^{68}\text{Ga}$ (for prostate cancer PSMA imaging and neuroendocrine DOTATOC scans) without an on-site cyclotron!

2. Targeted Alpha Therapy (TAT) Radionuclides

Alpha particles deposit extreme localized ionization ($\text{LET} \sim 100\text{ keV}/\mu\text{m}$) over a $40 - 80\,\mu\text{m}$ path length, delivering lethal double-strand DNA breaks to tumor cells while sparing neighboring normal tissues:

• Actinium-225 ($^{225}\text{Ac}$): $T_{1/2} = 9.92\text{ days}$, emits a cascade of 4 alpha particles ($^{225}\text{Ac} \to ^{221}\text{Fr} \to ^{217}\text{At} \to ^{213}\text{Bi} \to ^{209}\text{Pb}$). Conjugated to PSMA-617 for metastatic castration-resistant prostate cancer.
• Radium-223 ($^{223}\text{Ra}$ dichloride, Xofigo): $T_{1/2} = 11.43\text{ days}$, a natural calcium mimetic that targets osteoblastic bone metastases directly.

3. Industrial Sealed Radiation Sources

• Cobalt-60 ($^{60}\text{Co}$): Sealed double-encapsulated stainless steel pencils (activity up to $100\text{ kCi} \approx 3.7\text{ PBq}$) used for food irradiation, medical device sterilization, and industrial gamma radiography.
• Cesium-137 ($^{137}\text{Cs}$): Sealed ceramic pellets used for borehole geophysical well-logging and industrial level gauges.
• Americium-241 / Beryllium ($^{241}\text{Am}-\text{Be}$): Alpha-neutron source ($(\alpha, n)$ reaction on $^9\text{Be}$, emitting $\sim 2.2 \times 10^6\text{ n/s per Ci}$) for moisture gauges and neutron activation.

The synthesis of the heaviest transactinide elements ($Z \ge 104$, superheavy elements) tests the fundamental limits of nuclear existence and maps the predicted Island of Stability around spherical magic numbers $Z = 114, 120, 126$ and $N = 184$.

Synthesis Strategies: Cold Versus Hot Fusion

Superheavy elements are synthesized by bombarding heavy targets with high-intensity heavy-ion beams in specialized accelerators (e.g., GSI Helmholtzzentrum in Germany, JINR Flerov Laboratory in Dubna, RIKEN in Japan):

1. Cold Fusion Reactions (Peter Armbruster & Sigurd Hofmann, GSI):

• Target: Doubly magic lead-208 ($^{208}\text{Pb}$) or bismuth-209 ($^{209}\text{Bi}$).
• Projectiles: Medium-mass stable ions ($^{54}\text{Cr}, ^{58}\text{Fe}, ^{64}\text{Ni}, ^{70}\text{Zn}$).
• Characteristics: Low excitation energy of compound nucleus ($E^* \approx 10 - 15\text{ MeV}$). De-excites by boiling off only one prompt neutron ($1n$ channel).
• Synthesized elements $Z = 107 - 113$ (Bohrium through Nihonium).
• Limitation: Massive Coulomb barrier repulsion limits cross-sections for $Z \ge 114$ to the sub-picobarn regime ($<10^{-36}\text{ cm}^2$).

2. Hot Fusion with Calcium-48 Beams (Yuri Oganessian, Dubna):

• Projectile: Rare, neutron-rich doubly magic calcium-48 ($^{48}_{20}\text{Ca}_{28}$, $0.187\%$ natural abundance, cost $\sim \$250,000/\text{g}$).
• Targets: Transuranic actinide targets ($^{238}\text{U}, ^{244}\text{Pu}, ^{243}\text{Am}, ^{248}\text{Cm}, ^{249}\text{Bk}, ^{249}\text{Cf}$).
• Characteristics: The 8 neutron excess of $^{48}\text{Ca}$ forms compound nuclei closer to the predicted $N = 184$ neutron shell closure. Higher excitation energy ($E^* \approx 30 - 40\text{ MeV}$) de-excites via $3n$ and $4n$ evaporation channels.
• Synthesized elements $Z = 114 - 118$:
• Flerovium ($Z = 114$): $^{244}\text{Pu}(^{48}\text{Ca}, 3n)^{289}\text{Fl}$
• Moscovium ($Z = 115$): $^{243}\text{Am}(^{48}\text{Ca}, 3n)^{288}\text{Mc}$
• Livermorium ($Z = 116$): $^{248}\text{Cm}(^{48}\text{Ca}, 4n)^{292}\text{Lv}$
• Tennessine ($Z = 117$): $^{249}\text{Bk}(^{48}\text{Ca}, 3n)^{294}\text{Ts}$
• Oganesson ($Z = 118$): $^{249}\text{Cf}(^{48}\text{Ca}, 3n)^{294}\text{Og}$ ($\sigma \approx 0.5\text{ picobarn}$, barely 1 atom synthesized per month of continuous beam irradiation!).

Chemistry at the Relativistic Limit

At $Z = 118$, intense nuclear charge pulls inner $1s$ electrons to speeds approaching $85\%$ the speed of light ($v/c \approx Z\alpha \approx 118/137 \approx 0.86$). Relativistic mass increase contracts $s$ and $p_{1/2}$ orbitals while screening the nucleus and expanding $d$ and $f$ orbitals. Oganesson ($Z = 118$) is predicted to have an electron shell structure so modified by spin-orbit splitting that its valence electrons form a uniform electron gas (Fermi gas), predicting that Oganesson behaves not as a noble gas, but as a reactive semiconductor solid at room temperature!

Global Production Pathways of Major Medical and Industrial Radioisotopes

| Isotope | Half-Life | Primary Production Reaction | Production Facility | Carrier Status | Major Clinical / Industrial Use | | :--- | :--- | :--- | :--- | :--- | :--- | | $^{99}\text{Mo} \to ^{99m}\text{Tc}$ | $66.0\text{ h} / 6.0\text{ h}$ | $^{235}\text{U}(n, f)^{99}\text{Mo}$ | Research Reactor | Carrier-free (NCA) | $>80\%$ of all diagnostic nuclear medicine | | $^{131}\text{I}$ | $8.025\text{ days}$ | $^{130}\text{Te}(n, \gamma)^{131}\text{Te} \xrightarrow{\beta^-} ^{131}\text{I}$ | Research Reactor | Carrier-free (NCA) | Thyroid cancer ablation & hyperthyroidism | | $^{18}\text{F}$ | $109.8\text{ min}$ | $^{18}\text{O}(p, n)^{18}\text{F}$ | Biomedical Cyclotron | Carrier-free (NCA) | PET oncology imaging ($^{18}\text{F-FDG}$) | | $^{68}\text{Ge} \to ^{68}\text{Ga}$ | $271\text{ d} / 67.7\text{ min}$ | $^{69}\text{Ga}(p, 2n)^{68}\text{Ge}$ | High-energy Cyclotron | Generator system | PET neuroendocrine and prostate imaging | | $^{60}\text{Co}$ | $5.271\text{ years}$ | $^{59}\text{Co}(n, \gamma)^{60}\text{Co}$ | Heavy-water Reactor | Carrier-added | Industrial sterilization, gamma knife | | $^{192}\text{Ir}$ | $73.8\text{ days}$ | $^{191}\text{Ir}(n, \gamma)^{192}\text{Ir}$ | High-flux Reactor | High specific activity | Pipeline non-destructive testing, brachytherapy | | $^{225}\text{Ac}$ | $9.92\text{ days}$ | $^{226}\text{Ra}(p, 2n)^{225}\text{Ac}$ or $^{229}\text{Th}$ cow | Cyclotron / Generator | Carrier-free | Targeted Alpha Therapy (PSMA-617) |